Global B2B Pharmaceutical Marketplace Β· Sourcing Β· Named-Patient Access
πŸ’¬ WhatsApp Β· Sign in Β· Register

Explore Top Pharmaceutical Products, APIs, Formulations & Intermediates from Verified Suppliers

Nisoldipine

Strength:
8.5 mg, 17 mg, 34 mg

Form: Tablets

Reference Brands: Sular (USA)

View More Get Enquiry

Pentostatin

Strength:
10 mg

Form: Injection

Reference Brands: Nipent (USA/EU)

View More Get Enquiry

Nimodipine

Strength:
30 mg

Form: Tablet/ Injection

Reference Brands: Nimotop (USA)

View More Get Enquiry

Nilutamide

Strength:
150 mg

Form: Tablets

Reference Brands: Nilandron (USA), Nilandron (EU)

View More Get Enquiry

Axatilimab‑Csfr

Strength:
50β€―mg/mL

Form: Injection

Reference Brands: Niktimvo (USA)

View More Get Enquiry

Nicardipine Hydrochloride

Strength:
20β€―mg, 30β€―mg, 40β€―mg, 2.5β€―mg/mL

Form: Capsules / Injection

Reference Brands: Cardene (USA),

View More Get Enquiry

Somatrogon‑Ghla

Strength:
24β€―mg/1.2β€―mL, 60β€―mg/1.2β€―mL

Form: injection (prefilled syringe)

Reference Brands: Ngenla (USA)

View More Get Enquiry

Etonogestrel

Strength:
68 mg

Form: Subcutaneous implant

Reference Brands: Nexplanon (USA)

View More Get Enquiry

Neratinib Maleate

Strength:
40 mg

Form: Tablets

Reference Brands: Nerlynx (USA/EU)

View More Get Enquiry

Nemolizumab-Ilto

Strength:
30 mg/mL

Form: Injection

Reference Brands: Nemluvio (USA)

View More Get Enquiry

Nelarabine

Strength:
5 mg/mL

Form: Injection

Reference Brands: Arranon (USA)

View More Get Enquiry

Nefazodone Hydrochloride

Strength:
50 mg, 100 mg, 150 mg, 200 mg,250 mg

Form: Tablets

Reference Brands: Serzone (USA)

View More Get Enquiry

Nateglinide

Strength:
60 mg, 120 mg, 180 mg

Form: Tablets

Reference Brands: Starlix (USA)

View More Get Enquiry

Natamycin

Strength:
5%

Form: Ophthalmic Solution

Reference Brands: Natacyn (USA/EU)

View More Get Enquiry

Naratriptan Hydrochloride

Strength:
1 mg, 2.5 mg

Form: Tablets

Reference Brands: Amerge (USA/EU)

View More Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.